Abstract:BACKGROUND: The glial scar formation after spinal cord injury in mammals is the physical and chemical barriers for neural regeneration, and relieving or delaying glial scar formation can provide benefit conditions for the regeneration of injured spinal cord.OBJECTIVE: To design and screen short hairpin RNA (shRNA) interfere molecular targeting the gene coding region of glial fibrillary acidic protein (GFAP) in rat, and reconstruct the eukaryotic vector of shRNA.DESIGN: An observational animal experiment.SETTING: Department of Spine Surgery, Shenzhen Hospital affiliated to Southern Medical University.MATERIALS: Twenty-five Wistar rats of clean degree, either male or female, weighing 20-25 g, were used. DMEM/F12,lipofectamine2000, Trizol RNA separating kits); fetal bovine serum (Hyclone); BamH Ⅰ, HindⅢ, Pstl, Sail and T4 ligases;Plasmid mini preparation kit and DNA gel extraction kit.METHODS: The experiments were carried out in the Shenzhen Hospital affiliated to Southern Medical University from October 2005 to June 2006. Three pairs of shRNA template which composed of 19 bp reverse repeated motif of GFAP target sequence with 9 bp spacer were designed and synthesized, then they were inserted directionally into plasmid Psilencer 2.1 respectively to generate small interfering RNA (siRNA) eukaryotic expression vector. ShRNA molecules were transfected by liposome via ex vivo expression repressive model of GFAP of rat spinal astrocytes. The effects of expressive suppression were detected with real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot, and then the optimal shRNA eukaryotic vector of repressive expression of GFAP was screened.MAIN OUTCOME MEASURES: ① Interfering sequence specific shRNA template synthesis; ② Constructing specific recombinant plasmid eukaryotic expression vector. ③ Culturing rat spinal astrocytes in vitro; ④ Effects of expressive suppression on GFAP in primary astrocytes after RNA interference detected with real-time fluorescence quantitative RT-PCR and Western blot.RESULTS: Sequence analysis showed that GFAP-shRNA recombinant plasmid eukaryotic expression vector was successfully constructed, and optimal GFAP-shRNA eukaryotic vector was screened using real-time fluorescence quantitative RT-PCR and Western blot. The GFAP expressions were reduced by 81%, 63% and 56% at the levels of mRNA and protein respectively.CONCLUSION: GFAP-shRNA eukaryotic expression vectors were successfully constructed and screened. The gene expression GFAP of primitive rat astrocyte can be suppressed significantly by the GFAP-shRNA eukaryotic expression recombinant optimized via ex vivo cellular expression suppression model, which should pave the way for the following multiple targets of RNAi genetic manipulation in the treatment of suppression of glial scar formation after spinal cord injury.

Construction of Eukaryotic Expression Plasmid Expressing Shrna Targeting VEGF and NGF

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

The Generation of Eukaryotic Expression Vector of ShRNA Specific for VEGF Receptors Flt-1 and KDR

Construction of Psuper-H1 RNAi System Inhibiting the Expression of VEGF

Construction and Identification of Ph1-Ephb4-shrna Expression Vector

Construction and Identification of Lentiviral Vector-mediated RNA Interference of VEGF Gene

Vascular Endothelial Growth Factor Shrna Mediated by Pegfp-H1 Vector Plasmid Effectively Inhibits Glioma Proliferation: an Experimental Study

Construction of a Lentiviral Vector Carrying Shrna Against HIF-1α and Generation of a GL261 Cell Line Stably Transfected with This Vector

Construction of Targeting-VEGF shRNA Plasmid and Observation of its Inhibitory Effect on Tca8113 Cells

Optimal Screening of Shrna Molecules and Reconstruction of the Shrna Eukaryotic Expression Vector of GFAP Expressive Suppression of Rat Spinal Cord-Derived Astrocytes

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human Vascular Endothelial Growth Factor Short Hairpin RNA

Construction and identification of lentiviral vector of the RNA interference of human Nanog gene

Construction of vector specifically expressed vascular endothelial growth factor gene in endothelial cells and research of its expressive character

Optimal Screening of Short Hairpin and Construction of Its Eukaryotic Expression Vector for Glial Fibrillary Acidic Protein

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Inhibits Expression of Vascular Endothelial Cell in Human GBC-SD Cells

Construction of Herg Shrna Expression Vectors and Establishment of Its Stably Transfected Osteosarcoma Cell Lines MG-63 and SOSP-9607

Knockdown of VEGF-A expression in neuroblastoma cell line SH-SY5Y by RNA interference

Construction and Effect Identification of VEGF - C Eukaryotic Expression Vector for RNA Interference

Construction and Assessment of Short-Hairpin Rna Eukaryotic Expression Vector Targeting Tgf-Beta 1 Labeled by Gfp

Construction and Identification of Eukaryotic Expression Plasmid Encoding Shrna Against CXCR1 Gene

Construction and Identification of shRNA Eukaryotic Expression Vectors Targeting to EZH2 Gene